SHELL ASSET MANAGEMENT CO - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$282
-99.9%
7,405
-17.4%
0.01%
-14.3%
Q3 2022$351,000
-3.8%
8,961
-20.8%
0.01%
+27.3%
Q2 2022$365,000
-2.4%
11,309
+0.2%
0.01%
+22.2%
Q1 2022$374,000
-32.1%
11,291
-12.9%
0.01%
-18.2%
Q4 2021$551,000
+21.4%
12,963
+26.5%
0.01%
+10.0%
Q3 2021$454,000
-25.2%
10,251
-4.1%
0.01%
-16.7%
Q2 2021$607,000
-19.8%
10,691
+5.7%
0.01%
-20.0%
Q1 2021$757,000
+99.2%
10,111
+130.4%
0.02%
+87.5%
Q4 2020$380,000
+41.8%
4,3880.0%0.01%
+33.3%
Q3 2020$268,000
+47.3%
4,3880.0%0.01%
+20.0%
Q2 2020$182,000
+42.2%
4,388
-1.9%
0.01%
+25.0%
Q1 2020$128,000
-61.0%
4,473
-1.5%
0.00%
-42.9%
Q4 2019$328,000
-50.0%
4,543
-2.8%
0.01%
-53.3%
Q3 2019$656,000
-24.0%
4,675
-0.8%
0.02%
-21.1%
Q2 2019$863,000
+12.5%
4,715
-2.3%
0.02%
+11.8%
Q1 2019$767,000
+230.6%
4,824
+99.3%
0.02%
+183.3%
Q4 2018$232,000
-37.3%
2,420
-7.6%
0.01%
-14.3%
Q3 2018$370,000
-9.8%
2,6200.0%0.01%
-12.5%
Q2 2018$410,000
-6.4%
2,620
-3.7%
0.01%
-11.1%
Q1 2018$438,0002,7200.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders